Nymox Pharmaceautical Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nymox Pharmaceautical Corporation

NYMXF 0.106

0.0%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Zurowski who wrote (22)	3/20/1998 12:54:00 PM
From: Apple Jacks	Read Replies (1) of 28

Well, as luck would have it I want everyone to have look at an article in today's Report On Business section of The Globe & Mail (a Canadian newspaper). The article is available on-line at theglobeandmail.com It summarizes most of my views and in fact only increases my skepticism. By the way, I have received the paper JAD paper from Nymox themselves. Please note the following points: 1) Everyone should know that this is the debut issue of the Journal of Alzheimer's Disease and the editor of the Journal is none other than a Nymox consultant who has been working for them since May, 1996. REACH YOUR OWN CONCLUSIONS! 2)If this were a real breakthrough it would have been in Science or Nature. 3)Who's on the BOD doesn't always mean anything. Bre-X had some good Directors. 4)I haven't met one clinician, academic, investor, or biotech analyst who has had anything positive to say about Nymox. Maybe it's just the people that I know!? 5)I have seen a lot of patents that claim a lot but have never materialized. Do you think all the patent reviewers are AD experts? Holding a patent isn't as good an indicator of how good the science is compared to publishing in reputable journals. It really hasn't been peer-reviewed! If in a couple of months time, the scientific community embraces the "revolutionary" work Nymox has done then great! I would be wrong and I wouldn't care because there would now be some even more hope for the millions of AD sufferers. 6) Please remember that they are a few years away from being in Phase II or III, when the compound's efficacy will really be known. BTW, I am not shorting the stock. There is no financial gain in this for me. I am just looking for the truth.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next